Health
Vaccine by Christmas amid record cases in the US – News Mail
The Oxford vaccine trial has produced a positive response, as more than half US states reported their highest day of new cases.
A vaccine candidate for COVID-19 developed by the University of Oxford with the backing of pharmaceutical giant AstraZeneca has produced positive results.
The test jabs have triggered robust immune responses in adults.
According to Bloomberg, findings from blood tests which were carried out on a group of older trial participants reinforce data released in July which suggest the vaccine is effective for adults aged between 18 and 55, Astra announced on Monday local time.
Results from the study show…
-
Noosa News24 hours agoFarmers angry as Woolworths imports US butter in green and gold packaging
-
Noosa News9 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
General20 hours agoLiberal politicians on Qantas plane that made urgent turnaround to Adelaide
-
General9 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth